- 3 updates
Doctors will randomly treathalf the patients with a harmless virus carrying a corrective gene. The restwill receive an inactive placebo treatment.
Previous research suggests that a protein produced by the gene can restore function to failing hearts, and reduce the risk of death and heart transplants.
A revolutionary gene therapy treatment forheart failure is to be trialed at a London Hospital. Over the next three to six weeks, patients with severe chronic heart failure, will be treated by doctors at the Royal Brompton Hospital.